ストックスクリーナーアプリを入手
2.45
2.08%
0.05
アフターアワーズ：
2.44
-0.01
-0.41%
前日終値:
$2.40
開ける：
$2.41
24時間の取引高:
6.66M
Relative Volume:
0.70
時価総額：
$2.32B
収益：
$1.31M
当期純損益:
$-597.65M
株価収益率:
-2.5258
EPS:
-0.97
ネットキャッシュフロー:
$-425.62M
1週間 パフォーマンス:
-1.21%
1か月 パフォーマンス:
-10.26%
6か月 パフォーマンス:
-0.81%
1年 パフォーマンス:
-30.99%
1日の値動き範囲:
$2.41
$2.49
1週間の範囲:
$2.38
$2.67
52週間の値動き範囲:
$1.83
$7.48
Immunitybio Inc Stock (IBRX) Company Profile
IBRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IBRX
Immunitybio Inc
|
2.45 | 2.27B | 1.31M | -597.65M | -425.62M | -0.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
419.10 | 106.87B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
491.22 | 63.14B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.77 | 61.27B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
849.46 | 51.94B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
167.91 | 35.04B | 398.11M | -1.03B | -868.57M | -5.7032 |
Immunitybio Inc Stock (IBRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-20 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2025-03-06 | 開始されました | H.C. Wainwright | Buy |
| 2025-01-10 | 開始されました | BTIG Research | Buy |
| 2023-05-12 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-08-03 | 開始されました | Jefferies | Buy |
Immunitybio Inc (IBRX) 最新ニュース
Why ImmunityBio Inc. (26CA) stock benefits from AI revolutionTrade Ideas & High Accuracy Swing Entry Alerts - newser.com
Published on: 2025-10-20 12:10:55 - newser.com
Applying big data sentiment scoring on ImmunityBio Inc.Earnings Risk Report & Fast Gain Stock Tips - newser.com
ImmunityBio Inc. stock trend outlook and recovery pathLong Setup & Free Growth Oriented Trading Recommendations - newser.com
Why ImmunityBio Inc. (26CA) stock is a strong analyst pickShare Buyback & Community Consensus Trade Alerts - newser.com
Tick level data insight on ImmunityBio Inc. volatilityQuarterly Trade Report & Precise Buy Zone Tips - newser.com
Will ImmunityBio Inc. stock outperform tech sector in 2025Market Sentiment Report & Technical Entry and Exit Alerts - nchmf.gov.vn
Short interest data insights for ImmunityBio Inc.Trade Entry Report & Fast Moving Trade Plans - newser.com
Is ImmunityBio Inc. stock a buy on dipsWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
Will ImmunityBio Inc. stock split again soon2025 Trading Volume Trends & Technical Entry and Exit Tips - nchmf.gov.vn
How ImmunityBio Inc. stock reacts to job market data2025 Market Trends & Weekly Market Pulse Alerts - nchmf.gov.vn
Can machine learning forecast ImmunityBio Inc. recovery2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Institution Moves: Will ImmunityBio Inc. stock outperform tech sector in 20252025 Support & Resistance & Stepwise Swing Trade Plans - nchmf.gov.vn
Discover ImmunityBio And Two Other Growth Stocks With High Insider Ownership - simplywall.st
Is ImmunityBio Inc a good long term investmentResistance Breakout Alerts & Unlock Free Weekly Portfolio Checkups - earlytimes.in
Will ImmunityBio Inc. stock benefit from infrastructure spendingJuly 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com
Will ImmunityBio Inc. rebound enough to break evenBear Alert & Community Consensus Picks - newser.com
How to recover losses in ImmunityBio Inc. stockJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com
Published on: 2025-10-11 12:10:43 - earlytimes.in
ImmunityBio, Inc.Common Stock (NQ: IBRX - FinancialContent
Why Immunitybio Inc. (IBRX) Soared on Thursday - MSN
ImmunityBio, Inc. (IBRX) Reports Strong Q2 Growth, Eyes Lung Cancer and NMIBC Expansion - MSN
ImmunityBio, Inc. (26CA.F) stock price, news, quote and history - Yahoo
Will EnGene Join The Ranks Of Merck, Ferring, And ImmunityBio In Bladder Cancer Treatment? - RTTNews
IBRX stockholders via consent approve 1.65B common share authorization - Stock Titan
Real time social sentiment graph for ImmunityBio Inc.2025 Pullback Review & Accurate Intraday Trading Signals - newser.com
Evaluating ImmunityBio Inc. with trendline analysis2025 Major Catalysts & Growth Oriented Trading Recommendations - newser.com
Is ImmunityBio Inc. (26CA) stock prepared for digital transitionJuly 2025 Technicals & Smart Allocation Stock Tips - newser.com
ImmunityBio Inc. stock retracement – recovery analysis2025 Investor Takeaways & AI Enhanced Trading Signals - newser.com
ANKTIVA Reimbursement Gains and UK Approval Might Change The Case For Investing In ImmunityBio (IBRX) - Sahm
ImmunityBio, Inc. (NASDAQ:IBRX) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
What Went Wrong With ImmunityBio’s Executives Claims — and How Investors Could Still Win - TradingView
ImmunityBio: A Small Bet Is Warranted (NASDAQ:IBRX) - Seeking Alpha
NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com
Does ImmunityBio Inc. show high probability of reboundJuly 2025 Pullbacks & Stepwise Trade Signal Implementation - newser.com
Immunitybio Inc (IBRX) 財務データ
収益
当期純利益
現金流量
EPS
1.03%
2.67%
大文字化:
|
ボリューム (24 時間):